iRadimed
IRMD
86 hedge funds and large institutions have $169M invested in iRadimed in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 9 closing their positions.
0.86% more ownership
Funds ownership: 43.98% → 44.84% (+0.86%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
4% less funds holding
Funds holding: 90 → 86 (-4)
10% less capital invested
Capital invested by funds: $187M → $169M (-$18.4M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCG
Resource Consulting Group
Orlando,
Florida
|
+$4.46M |
| 2 |
BCM
Bares Capital Management
Austin,
Texas
|
+$3.3M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.23M |
| 4 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$1.81M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$553K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aviva
London,
United Kingdom
|
-$2.08M |
| 2 |
Renaissance Technologies
New York
|
-$1.6M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.3M |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$686K |
| 5 |
Millennium Management
New York
|
-$666K |
IRMD Hedge Fund Activity: Q3 2022 in Review
86 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2022, worth a combined $169M — down 9.8% from $187M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of IRMD and 5 opened new positions — a net loss of 4 holders — while 32 trimmed existing stakes and 30 added.
The largest buyer was Resource Consulting Group, opening a new position worth an estimated $4.46M. The largest seller was Aviva, exiting entirely with an estimated $2.08M sold.
- 86 institutional investors held iRadimed (IRMD) as of Q3 2022, down from 90 in Q2 2022.
- Funds reported $169M of iRadimed stock for Q3 2022, down 9.8% quarter-over-quarter.
- 5 funds opened new iRadimed positions in Q3 2022 and 9 closed out, a net change of -4 holders.
- The largest iRadimed buyer in Q3 2022 was Resource Consulting Group, an estimated $4.46M added.
- The largest iRadimed seller in Q3 2022 was Aviva, an estimated $2.08M sold.
Based on aggregated 13F filings for Q3 2022.